It has been suggested, mainly by in vitro findings, that cardiovascular tissue in the spontaneously hypertensive rat (SHR) should be more prone to proliferate/hypertrophy than that of the Wistar-Kyoto rat (WKY). The present study tests the hypothesis that the tissue of the lowpressure compartment in SHR, being structurally similar to that of the WKY, shows an increased growth response due to activation of the GH-IGF-I system.
Introduction
The spontaneously hypertensive rat (SHR) shows that adaptive structural changes occur in the left ventricle (LV) and the resistance vessels both in the early stage and during the development of hypertension (Folkow 1982 . In contrast, the right ventricle (RV) shows no signs of hypertrophy compared with that in normotensive rats (Friberg 1985 , Oka et al. 1993 , Dilley et al. 1994 .
In SHR, both an increase in number (Mulvany et al. 1985) and size of vascular smooth muscle cells (VSMC) have been suggested to be responsible for the augmented blood vessel wall mass (Owens & Schwartz 1982) . Several in vitro studies have demonstrated that VSMC cultured from SHR aorta replicate faster, and these cells have also been shown to possess increased responsiveness to growth factors (Hadrava et al. 1989 , Scott Burden et al. 1989 , Bukoski et al. 1991 , Grammas et al. 1994 , as well as being less responsive to the growthinhibitory transforming growth factor-1 (TGF-1) than cells from Wistar-Kyoto rats (WKY) (Hamet et al. 1991 , Saltis & Bobik 1992 , Saltis et al. 1992a , Tremblay et al. 1992 , Sato et al. 1995 . The question whether an exaggerated cardiovascular growth potential in SHR occurs also in vivo is difficult to study, since the 'structural baseline' is already offset compared with normotensive rats. Nevertheless, Dilley et al. (1994) demonstrated that VSMC in SHR are more reactive to growth stimuli induced by two-kidney, one-clip (2K1C) renal hypertension, corroborating in vitro data (Bukoski et al. 1991 , Hamet et al. 1991 , Saltis & Bobik 1992 , Saltis et al. 1992a ,b, 1993 , Tremblay et al. 1992 , Grammas et al. 1994 , Sato et al. 1995 . Likewise, LV weight increased to a greater magnitude in renal hypertensive SHR vs WKY-2K1C, despite a smaller relative increase in systolic blood pressure (SBP) (Dilley et al. 1994) , supporting previous findings (Friberg & Nordborg 1986) . Considered collectively, these in vitro and in vivo findings may indicate an accelerated growth potential in hearts and VSMC in SHR for a given stimulus compared with normotensive rats.
Given that previous work in SHR, with regard to cell growth, has focused mainly on the LV and in vitro 'arterial' cell culture systems, little is known about in vivo growth responses of the RV and the low-pressure compartment during increased haemodynamic demand. The RV and caval vein in SHR are apparently similar with regard to weight to those in WKY, and there is no difference at baseline either in central venous pressure (CVP) and right atrial pressures, or in neurohumoral factors, such as noradrenaline and the reninangiotensin system, between the strains (Oka et al. 1993) .
Circulatory alterations, induced by an aortocaval fistula (ACF), involve increased volume flow from the arterial to the venous compartment, resulting in a widening of the caval vein and the RV. As a result using the ACF model in normotensive rats (Garcia & Diebold 1990) , an increased early expression of both the insulin-like growth factor-I (IGF-I) and the growth hormone (GH) receptor mRNAs in the RV and caval vein, respectively, has been demonstrated (Isgaard et al. 1994 , Wickman et al. 1997 , supporting the contention that the over-expression of the GH-IGF-I system may be mediated via increased mechanical loading. Although it is important to acknowledge the role for other growth factors, besides the IGF-I and the GH-IGF-I system, these latter components have been strongly implicated in cardiovascular tissue growth (Lever & Harrap 1992 , Ito et al. 1993 , Friberg et al. 1995 . To test the hypothesis that the SHR also in the low-pressure compartment, being structurally similar to that of the WKY, demonstrates increased tissue growth for a given stimulus, the present study characterises, in the ACF model applied to both SHR and WKY: (i) magnitude and time-course of changes in RV weight in relation to the expression of GH-IGF-I system components (IGF-I, IGF-I receptor and GH receptor mRNAs) in the RV and the inferior caval vein respectively and (ii) immediate changes in CVP (radio-telemetry) as well as in SPB (tail-cuff technique).
Materials and Methods

Surgical procedures
Animals Age-matched SHR and WKY male rats were obtained from Möllegaard Breeding Center Ltd (Ejby, Denmark). The animals arrived 1 week prior to experimentation. They had free access to standard pellet chow and tap water throughout the study. All experiments were approved by the Regional Animal Ethics Committee in Göteborg.
ACF During short-lasting barbiturate anaesthesia (75 10 -3 g/kg body weight i.p. methohexital sodium; Brietal; Eli-Lilly and Co., Indianapolis, IN, USA), an ACF was created in SHR and WKY (n=8 for both strains at each time-point) rats weighing approximately 180 g, by means of a fistula between the aorta and the inferior caval vein (Garcia & Diebold 1990 ). The abdominal aorta was punctured with a 18 gauge disposable needle and advanced into the inferior caval vein. After withdrawing the needle, the puncture site was sealed with cyanoacrylate glue. Before closing the abdomen, the patency of the shunt was confirmed visually (mixing of arterial blood in the caval vein). A sham operation was performed in SHR and WKY (n=6 at each time-point) including free dissection of both the aorta and the inferior caval vein. Hence, the sham operation was similar to the ACF surgery, with the exception of the actual vessel puncture.
The degree of ACF was moderate without signs of cardiac failure, as demonstrated by no significant change in liver and lung wet weight to dry weight ratios (data not shown). To confirm the patency of ACF on the day of experimentation, the presence of systolic murmur was checked by auscultation. Only ACF animals showing clear-cut cardiac hypertrophy (>2 .. at any time-point) were included in the study. One rat at day 1 both in SHR-sham and SHR-ACF, one rat at day 2 in SHR-ACF, one rat at day 4 in SHR-sham, one rat at day 2 in WKY-sham, one rat at day 4 in WKY-ACF and one rat from both WKY-sham and WKY-ACF were excluded from the study due to the above exclusion criterion and to unexpected death during surgical procedures.
Radio-telemetry
In separate groups of SHR and WKY rats, radio-telemetric transducers (model TA11PA-C40; Data Sciences Inc., St Paul, MN, USA) were implanted 1 week prior to ACF surgery. The catheter of the transducer was placed into the inferior caval vein (n=4 for SHR and n=3 for WKY), and the catheter tip was faced in the proximal direction. The catheter was held in place by adding cyanoacrylate glue. The radio transmission was received by plates (RA1010; Data Sciences Inc) placed directly under the rat's cage, and the digital signal was transferred via a consolidation matrix (BCM100; Data Sciences Inc) to a computer-based data acquisition system (Dataquest IV, Version 4; Data Sciences Inc). Venous pressures were collected on-line at 150 Hz, for 15 s at 5-min intervals for each animal. CVP was monitored by the Dataquest IV software program and stored for subsequent analysis. The ACF was created at approximately the same level as the telemetry catheter tip. During ACF surgery, pressure monitoring was stopped for 30-45 min. CVP was then followed for 16 h.
Experimental protocol
Experiments were performed on SHR-ACF, SHR-sham, WKY-ACF and WKY-sham rats 1, 2, 4 and 7 days post-operatively. At days 1, 2, 4 and 7, SBP was measured by tail plethysmography (Narco BioSystems, Houston, TX, USA). Following anaesthesia, the rats were weighed and the heart and inferior caval vein excised. The tissue was trimmed free, the heart was separated into LV including septum, and RV and weighed before being snap frozen in liquid nitrogen and stored at 80 C.
Molecular biology
The GH receptor probe The pT7T3 18 U plasmid contains a 560 bp BamHI fragment of the rat GH receptor cDNA which encodes the early part of the extracellular domain of the GH receptor and, thus, does not differentiate between the GH receptor and the GH-binding protein. Antisense GH receptor 35 S-UTP labelled RNA was synthesised according to the manufacturer's instructions (Promega, Madison, WI, USA).
The IGF-I probe A 153 bp SmaI fragment of a genomic subclone of mouse IGF-I (exon 3 by analogy to human IGF-I) subcloned into a pSP64 plasmid was used as a template for probe synthesis (Mathews et al. 1986 ). The plasmid was linearised with EcoRI and used as template for synthesis of 35 S-UTP labelled IGF-I cRNA with SP6 RNA polymerase according to the manufacturer's instructions (Promega).
The IGF-I receptor probe The RNA probe was synthesised from a 265 bp fragment of the rat IGF-I receptor cDNA subcloned into a plasmid vector pGEM-3 (Werner et al. 1989) . The vector was linearised with EcoRI and the rat IGF-I receptor antisense RNA was synthesised using SP6 RNA polymerase and 35 S-UTP. Synthesis of the rat IGF-I receptor sense RNA standard was achieved using BamH1 for linearisation of the plasmid and addition of T7 RNA polymerase.
Solution hybridisation
Frozen tissue was homogenised, treated with proteinase-K and total nucleic acids (TNA) were extracted with phenol-chloroform as described previously (Durnam & Palmiter 1983) . A solution hybridisation assay was used to quantify IGF-I, IGF-I receptor and GH receptor mRNAs (Durnam & Palmiter 1983) . The probes were hybridised to TNA samples at 70 C for 24 h. After RNase treatment the precipitated protected hybrids were then collected on glass-fibre filters (GF/C Whatman; Whatman International Ltd, Maidstone, Kent, UK) and counted in a scintillation counter. The signal was compared with a standard curve based on known amounts of IGF-I, IGF-I receptor or GH receptor mRNAs. The results were related to the DNA content in the TNA sample (Labarca & Paigen 1980) . The probes have been verified by RNase protection (Guron et al. 1996 , Wickman et al. 1997 .
Statistical analysis
Values are given as means .. All cardiac weights and mRNA values were found to be normally distributed. The statistically significant difference between groups was analysed by three-way ANOVA followed by Fisher's LSD post-hoc test. Two-tailed unpaired Student's t-test was used for telemetry data by averaging CVP 4 h before and between 2 and 16 h after ACF surgery, and between strains for the same time-period. A P value less than 0·05 was considered statistically significant.
Results
Blood pressure
By using the tail-cuff method, all SHR-sham rats showed a statistically significant increase in SBP during the study period compared with WKY-sham (P<0·05, Fig. 1 ). The SBP was reduced in both SHR-ACF and WKY-ACF rats during the whole study period compared with their respective sham-operated group (P<0·05, Fig. 1 ). The SBP in SHR-ACF decreased to a greater extent than in WKY-ACF, in response to the fistula opening (P<0·05, Fig. 1 ). There was no difference in baseline CVP between SHR and WKY pre-ACF, being approximately 3-4 mmHg (Fig. 2) . SHR showed a transient increase in CVP from 2·9 5·1 mmHg before ACF to 6·4 9·3 mmHg as averaged over 16 h following fistula opening (P<0·05). CVP returned thereafter to pre-ACF levels (Fig. 2) . In contrast, WKY-ACF rats showed similar levels of CVP before and after ACF surgery; 4·7 2·2 vs 5·3 2·5 mmHg before and during 16 h after fistula opening (Fig. 2) .
RV weight
Both sham-operated SHR and WKY groups demonstrated similar RV weights at the studied time-points (Table 1 ). All ACF rats showed statistically significant increases in RV weight already by 24 h after the fistula opening (Table 1, Fig. 3 ). RV weight increased progressively and to a similar magnitude in both SHR and WKY after ACF surgery compared with their respective sham group (Fig. 3) . At day 2, however, SHR-ACF showed a statistically significant greater increase in RV weight compared with WKY-ACF (Table 1, Fig. 3 ).
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IGF-I mRNA expression
The increased haemodynamic demand caused induction of IGF-I mRNA in both the RV and the caval vein in both groups (Table 1) . In SHR-ACF rats, the RV and the caval vein showed a transient and lower IGF-I mRNA expression compared with that in the WKY-ACF group (Table 1, Fig. 4 ). Similar to the RV IGF-I mRNA expression in the SHR-ACF group, the caval vein showed the highest IGF-I mRNA expression at day 2 after shunt opening (Table 1, Fig. 4) . It is our experience that cardiac IGF-I mRNA expression shows some biological variation in sham animals. Although RV IGF-I mRNA in sham WKY at day 4 demonstrated a slightly lower value compared with the other sham IGF-I mRNA values, there was no statistically significant difference either with respect to strain or to time.
GH receptor and IGF-I receptor mRNAs expression
The volume-loaded WKY rats showed an enhanced expression of both RV GH receptor and IGF-I receptor mRNAs expression vs SHR-ACF rats (P<0·05, Fig. 5 ).
There were no changes above control level in RV GH receptor mRNA expression in any of the SHR-ACF rats; it was even reduced at day 7. Interestingly, in the SHR-sham groups, the expression of RV GH receptor mRNA showed a statistically significant consistent, approximately twofold increase, compared with shamoperated WKY (Table 1 ). There was, however, a significant elevation of RV GH receptor mRNA expression at day 7 in WKY-ACF rats vs WKY-sham rats (Table 1, Fig. 5 ). Moreover, there were no changes in RV IGF-I receptor mRNA expression detected at any time-point in the SHR-ACF group, whereas the RV IGF-I receptor mRNA expression in WKY rats increased only at four days after ACF surgery (Table 1, Fig. 5 ). No change in IGF-I receptor mRNA expression was observed over time in RV in sham-treated animals.
Discussion
The main finding of the present study was that a haemodynamic load caused attenuated RV and caval vein mRNA induction of IGF-I, its receptor and GH receptor in SHR compared with WKY. These were also turned off more quickly. The biological and functional hypertrophic response in the RV in SHR was, however, similar to that in WKY rats, suggesting an increased growth response for a given IGF-I mRNA activation in the former. An advantage in the present study was that both strains started with similar RV weights and CVP and, after the induction of the fistula, SHR showed a faster onset of RV hypertrophy and a transient elevation of venous pressure. The latter phenomenon may be related to the faster onset of IGF-I mRNA induction noted in the inferior caval vein 2 days following fistula opening. Over the 7-day experimental period, SBP fell to a greater extent in SHR vs WKY, probably reflecting a more hyperkinetic circulation in the former. This suggests that SHR require less GH-IGF-I system activation to yield a given amount of RV structural adaptation compared with WKY, which may be explained by an inherent increase in the GH-IGF-I system sensitivity in the heart and vasculature. An alternative explanation could be that the GH-IGF-I axis is of limited importance for the haemodynamic structural adaptation of the cardiovascular system in SHR compared with other trophically acting agents, such as platelet-derived growth factor or TGF-. One may also argue, however, that the different haemodynamic response to ACF in the two strains may have influenced the various gene expressions, since the SHR-ACF group showed a more prominent blood pressure fall compared with the WKY fistula group.
When a fistula is created between abdominal aorta and inferior caval vein in normotensive rats the low-pressure compartment will be exposed to a sustained increase of volume flow and a consequent decrease of arterial blood pressure and total peripheral resistance as well as an increase of right atrial pressure (Huang et al. 1992 , Ruzicka et al. 1993 , Ruzicka & Leenen 1995 , but without concurrent changes in CVP (Wickman et al. 1997) . When this ACF model was applied to SHR, there was an immediate, transient increase in CVP, which did not occur in WKY, probably reflecting a greater volume flow across the fistula for the first few hours. These haemodynamic changes in the SHR-ACF will, in turn, also activate neurohumoral factors, and apparently to an even greater extent than in WKY-ACF rats (Oka et al. 1993) , corroborating our data showing evidence for a greater fistula volume flow in SHR vs WKY. However, the present study showed that the CVP had already normalised within 12 to 16 h after fistula opening in SHR, suggesting a haemodynamic profile more like the one in WKY for the remaining study period. 
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The mechanisms for transforming a mechanical stimulus, due to augmented volume/pressure load on the heart and vessels, into a structural growth response are unclear, although several factors, such as immediate/early growth markers/factors (e.g. proto-oncogenes (Schunkert et al. 1991) and TGF- (Komoro et al. 1991) ) and early/late growth factor systems (e.g. GH-IGF-I) have been shown to be involved (Wåhlander et al. 1992 , Fath et al. 1993 , Donohue et al. 1994 , Delafontaine 1995 , Guron et al. 1996 . Thus, there is compelling evidence for the importance of the GH-IGF-I system, not only in the regulation of physiological adaptive cardiovascular hypertrophy, but it has also a role in the failing and infarcted myocardium (Fazio et al. 1996 ). The present study demonstrated IGF-I mRNA over-expression in two different tissues, the RV and the caval vein after induction of ACF, supporting previous findings in normotensive rats (Isgaard et al. 1994 , Wickman et al. 1997 . Surprisingly, both strains showed a rapid and substantial increase in RV weight in response to ACF surgery, being approximately 20% 24 h after shunt induction. Given that the GH-IGF-I system was not increased above control level during the initial 24 h, other systems must also be involved in generating growth (vide supra). Apparently, IGF-I mRNA expression comes into play in a later phase in the chain of growth factor events, here being over-expressed at 48 h after fistula induction in both cardiac and vascular tissues (Fig. 3) .
Although several in vitro studies have provided evidence for an increased proliferative response in SHR VSMC vs WKY (Bukoski et al. 1991 , Hamet et al. 1991 , Saltis & Bobik 1992 , Saltis et al. 1992a ,b, 1993 , Tremblay et al. 1992 , Grammas et al. 1994 , Sato et al. 1995 , Dilley et al. (1994) showed that renal hypertensive SHR exhibited a greater LV hypertrophic response and an augmented resistance vessel structural adaptation than was the case for WKY-2K1C, despite a smaller blood pressure increase in the former, suggesting that SHR are more prone to respond to a given haemodynamic challenge. However, their study design included vessels and LVs The experiments were performed 1, 2, 4 and 7 days after surgery. In both panels, a statistically significant difference was shown between strain, surgical intervention and time (three-way ANOVA, P<0·05). Data are means S.D. *P<0·05 between ACF and sham for the respective strain. #P<0·05 between SHR and WKY.
obtained from SHR that were already adapted structurally to an elevated work load, prior to the induction of the superimposed renal hypertension. Our approach, however, was to utilise non-haemodynamically challenged SHR tissues: the RV and the caval vein. Our in vivo results, showing less activation of the GH-IGF-I system in SHR for a given amount of RV hypertrophy thus agree with the conclusion put forward by Dilley et al. (1994) .
The present study demonstrated over-expression of GH receptor mRNA after the peak of IGF-I and IGF-I receptor mRNAs in volume-overloaded WKY rats, whereas the SHR-ACF group showed unchanged levels of GH receptor mRNA expression during haemodynamic overload. The reason for the elevated cardiac GH receptor expression observed in the WKY group and also previously (Isgaard et al. 1994 , Guron et al. 1996 , Wickman et al. 1997 ) is unclear, although it may indicate that the IGF-I gene expression response, and the subsequent protein synthesis, are not enough to create a sufficient adaptive hypertrophy in normotensive strains. Interestingly, the SHR-ACF group demonstrated no such elevation of RV GH receptor mRNA. This could be due to the fact that sham-treated SHR showed a twofold higher baseline level of RV GH receptor mRNA compared with WKY-sham, which may be sufficient to contribute to the adaptive RV growth response in this model of haemodynamic overload. However, it should be noted that it is presently not known if these increased levels of GH receptor mRNA are accompanied by an increase of functional GH receptors.
The present study also demonstrated a marked increase of the IGF-I receptor in the RV 4 days after surgery in WKY rats, but a lack of increased expression of RV IGF-I receptor mRNA in SHR-ACF. This suggests, at least in the normotensive strain, that an elevation of the IGF-I receptor mRNA expression would enhance the response to locally available IGF-I in the RV and contribute to the hypertrophic response, in agreement with the rapid and transient IGF-I receptor gene induction in the 2K1C hypertension (Guron et al. 1996) . However, whether the up-regulation of the IGF-I receptor gene expression during these haemodynamic challenges results in an increased number of receptors remains to established.
One limitation of this study is that we have, so far, only measured mRNA levels of components of the GH-IGF-I axis. However, a previous study from our group has demonstrated an accompanying increase in IGF-I protein when IGF-I gene expression is up-regulated during development of cardiac hypertrophy (Wåhlander et al. 1992) and in the caval vein (Wickman et al. 1997) .
Another limitation is that the present study was focused on the GH-IGF-I axis, and we are aware that other growth-related systems may be of equal or even more importance for the development of adequate structural cardiac growth in response to a haemodynamic overload. The opportunity for studying other growth factors in this experimental setting is somewhat difficult, since the amount of tissue from the caval vein and RV are restricted.
In summary, ACF volume-overloaded SHR showed a consistently lower magnitude of RV and vascular IGF-I mRNA induction than that observed in the volumeoverloaded WKY rats. The resultant RV hypertrophy was pronounced in both strains and it developed to a similar degree by the end of the study, indicating that IGF-I may be at least of some importance for the development of cardiovascular hypertrophy in both normotensive and hypertensive rats. One may speculate that the SHR possibly require less GH-IGF-I system activation for creating an adaptive hypertrophic growth compared with the WKY rat, at least for the myocardial and venous tissues in this model of volume overload.
